These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 22367029)
1. Syntheses and cell-based phenotypic screen of novel 7-amino pyrido[2,3-d]pyrimidine-6-carbonitrile derivatives as potential antiproliferative agents. Yang T; He H; Ang W; Yang YH; Yang JZ; Lin YN; Yang HC; Pi WY; Li ZC; Zhao YL; Luo YF; Wei Y Molecules; 2012 Feb; 17(3):2351-66. PubMed ID: 22367029 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of novel 2,4,5-substituted pyrimidine derivatives for anticancer activity. Xie F; Zhao H; Zhao L; Lou L; Hu Y Bioorg Med Chem Lett; 2009 Jan; 19(1):275-8. PubMed ID: 19028425 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives. Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor activity of pyrido [2,3-d]pyrimidine and pyrido[2,3-d] [1,2,4]triazolo[4,3-a]pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest. Fares M; Abou-Seri SM; Abdel-Aziz HA; Abbas SE; Youssef MM; Eladwy RA Eur J Med Chem; 2014 Aug; 83():155-66. PubMed ID: 24956552 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro antitumoral activity of new hydrazinopyrimidine-5-carbonitrile derivatives. Cocco MT; Congiu C; Lilliu V; Onnis V Bioorg Med Chem; 2006 Jan; 14(2):366-72. PubMed ID: 16185883 [TBL] [Abstract][Full Text] [Related]
6. 6-Substituted 2,4-diaminopyrido[3,2-d]pyrimidine analogues of piritrexim as inhibitors of dihydrofolate reductase from rat liver, Pneumocystis carinii, and Toxoplasma gondii and as antitumor agents. Gangjee A; Zhu Y; Queener SF J Med Chem; 1998 Nov; 41(23):4533-41. PubMed ID: 9804692 [TBL] [Abstract][Full Text] [Related]
9. Discovery of 8-cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carbonitrile (7x) as a potent inhibitor of cyclin-dependent kinase 4 (CDK4) and AMPK-related kinase 5 (ARK5). Reddy MV; Akula B; Cosenza SC; Athuluridivakar S; Mallireddigari MR; Pallela VR; Billa VK; Subbaiah DR; Bharathi EV; Vasquez-Del Carpio R; Padgaonkar A; Baker SJ; Reddy EP J Med Chem; 2014 Feb; 57(3):578-99. PubMed ID: 24417566 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of 5-methyl-5-deaza nonclassical antifolates as inhibitors of dihydrofolate reductases and as potential antipneumocystis, antitoxoplasma, and antitumor agents. Gangjee A; Shi J; Queener SF; Barrows LR; Kisliuk RL J Med Chem; 1993 Oct; 36(22):3437-43. PubMed ID: 8230134 [TBL] [Abstract][Full Text] [Related]
11. Novel 6-substituted benzoyl and non-benzoyl straight chain pyrrolo[2,3-d]pyrimidines as potential antitumor agents with multitargeted inhibition of TS, GARFTase and AICARFTase. Xing R; Zhang H; Yuan J; Zhang K; Li L; Guo H; Zhao L; Zhang C; Li S; Gao T; Liu Y; Wang L Eur J Med Chem; 2017 Oct; 139():531-541. PubMed ID: 28830032 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and in-vitro anti-proliferative evaluation of some pyrazolo[1,5-a]pyrimidines as novel larotrectinib analogs. Attia MH; Elrazaz EZ; El-Emam SZ; Taher AT; Abdel-Aziz HA; Abouzid KAM Bioorg Chem; 2020 Jan; 94():103458. PubMed ID: 31785854 [TBL] [Abstract][Full Text] [Related]
13. New functionalized 6-thienylpyrimidine-5-carbonitriles as antiproliferative agents against human breast cancer cells. AboulWafa OM; Daabees HMG; Hammad A; Badawi WA Arch Pharm (Weinheim); 2021 Nov; 354(11):e2100177. PubMed ID: 34347303 [TBL] [Abstract][Full Text] [Related]
14. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition. Maher M; Kassab AE; Zaher AF; Mahmoud Z Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of novel 2,4-bismorpholinothieno[3,2-d]pyrimidine and 2-morpholinothieno[3,2-d]pyrimidinone derivatives as potent antitumor agents. Ye T; Han Y; Wang R; Yan P; Chen S; Hou Y; Zhao Y Bioorg Chem; 2020 Jun; 99():103796. PubMed ID: 32283346 [TBL] [Abstract][Full Text] [Related]
16. 6-Cinnamoyl-4-arylaminothienopyrimidines as highly potent cytotoxic agents: Design, synthesis and structure-activity relationship studies. Toolabi M; Moghimi S; Bakhshaiesh TO; Salarinejad S; Aghcheli A; Hasanvand Z; Nazeri E; Khalaj A; Esmaeili R; Foroumadi A Eur J Med Chem; 2020 Jan; 185():111786. PubMed ID: 31671308 [TBL] [Abstract][Full Text] [Related]
17. Design and Green Synthesis of Thieno[2,3-d]pyrimidine Analogues as Potential Antiproliferative Agents. Gill RK; Kumar V; Bishnoi M; Yadav K; Kondepudi KK; Bariwal J Anticancer Agents Med Chem; 2017; 17(5):701-711. PubMed ID: 27539315 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and in vitro biological evaluation of novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing a thiosemicarbazide moiety. Geng PF; Liu XQ; Zhao TQ; Wang CC; Li ZH; Zhang J; Wei HM; Hu B; Ma LY; Liu HM Eur J Med Chem; 2018 Feb; 146():147-156. PubMed ID: 29407946 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents. Gangjee A; Adair OO; Queener SF J Med Chem; 2003 Nov; 46(23):5074-82. PubMed ID: 14584957 [TBL] [Abstract][Full Text] [Related]